CLINICAL_TRIALS
trial_result
· 2018-08-14
Clinical Trial Update: Study of Glycopyrronium in Axillary Hyperhydrosis [Phase 3]
Summary
A Phase 3 clinical trial evaluating glycopyrronium for axillary hyperhidrosis has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Journey Medical Corporation | Conditions: Hyperhidrosis | Phase 3 | Status: COMPLETED | Results posted: 2018-08-14